BioCryst PharmaceuticalsBCRX 
$7.960.51%24h
0.51%24h
Global rank5884
Market cap$1.63B
Change 7d3.65%
YTD Performance33.78%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of BioCryst Pharmaceuticals (BCRX)
As of November 2024, BioCryst Pharmaceuticals has a market cap of $1.63B. This makes BioCryst Pharmaceuticals the world's 5884th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of BioCryst Pharmaceuticals from 1994 to 2024
-
Value:-
Market cap history of BioCryst Pharmaceuticals from 1994 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.15B | -6.43% |
| 2023 | $1.23B | -47.82% |
| 2022 | $2.35B | -17.11% |
| 2021 | $2.84B | 85.91% |
| 2020 | $1.53B | 115.94% |
| 2019 | $706.59M | -57.25% |
| 2018 | $1.65B | 64.36% |
| 2017 | $1.01B | -22.43% |
| 2016 | $1.30B | -38.66% |
| 2015 | $2.11B | -15.13% |
| 2014 | $2.49B | 60.00% |
| 2013 | $1.56B | 435.21% |
| 2012 | $290.83M | -42.51% |
| 2011 | $505.88M | -52.22% |
| 2010 | $1.06B | -19.97% |
| 2009 | $1.32B | 371.53% |
| 2008 | $280.59M | -77.83% |
| 2007 | $1.27B | -46.54% |
| 2006 | $2.37B | -30.99% |
| 2005 | $3.43B | 189.79% |
| 2004 | $1.18B | -15.62% |
| 2003 | $1.40B | 613.54% |
| 2002 | $196.62M | -75.76% |
| 2001 | $811.04M | -40.23% |
| 2000 | $1.36B | -77.54% |
| 1999 | $6.04B | 321.43% |
| 1998 | $1.43B | 0.00% |
| 1997 | $1.43B | -57.25% |
| 1996 | $3.35B | 77.03% |
| 1995 | $1.89B | 100.00% |
| 1994 | $947.24M | - |
BCRX Market Cap Today is $1.63B 0.51% - 18 Nov 2024
View largest stocks by market cap 
